The connection between VEGF polymorphisms and BPD susceptibility offers a significant opportunity to incorporate genetic testing into neonatal care, aiming to reduce the incidence and severity of BPD in newborns. This evidence concerns the gene VEGFA and bronchopulmonary dysplasia.